Dr Kimberly Bruneau Petersen, MD | |
33296 Lone Pine Dr, Browerville, MN 56438-5108 | |
(708) 341-1891 | |
Not Available |
Full Name | Dr Kimberly Bruneau Petersen |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 33296 Lone Pine Dr, Browerville, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689748667 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 73796 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kimberly Bruneau Petersen, MD 33296 Lone Pine Dr, Browerville, MN 56438-5108 Ph: (708) 341-1891 | Dr Kimberly Bruneau Petersen, MD 33296 Lone Pine Dr, Browerville, MN 56438-5108 Ph: (708) 341-1891 |
News Archive
Macmillan Medical Communications (MMC) has welcomed Scott Carson as its new National Sales Manager. He will be reporting in to John Elduff, Senior VP of Sales, and will be based out of MMC's corporate sales office in Philadelphia, PA.
A new report published online today in the Journal of the Academy of Nutrition and Dietetics systematically reviews and updates the evidence underlying the recommendation in the Dietary Guidelines for Americans 2010 to consume a diet low in energy density.
Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has entered into a global collaboration with Pfizer Inc. for the development and potential commercialization of SPK-FIX, a development program advancing proprietary, bio-engineered adeno-associated virus (AAV) vectors for the potential treatment of hemophilia B.
Specifically asking young women during visits to family planning clinics whether their partners had attempted to force them to become pregnant - a type of intimate-partner violence called reproductive coercion - dramatically reduced the likelihood that the women would continue to experience such pressures, according to a new pilot study led by researchers at the UC Davis School of Medicine.
For disabling hand contractures caused by Dupuytren's disease, patients prefer a percutaneous needle fasciotomy procedure despite the higher contracture recurrence rate when compared to conventional surgery.
› Verified 6 days ago